Vaccine coverage in CF children: A French multicenter study

Journal of Cystic Fibrosis

Volumn 14, Issue 5, 2015, Pages 615-620

  Masson, A ^a   Launay, O ^b,c   Delaisi, B ^d   Bassinet, L ^e   Remus, N ^e   Lebourgeois, M ^a   Chedevergne, F ^a   Bailly, C ^a   Foucaud, P ^f   Corvol, H ^g   deBlic, J ^a,c   Sermet Gaudelus, I ^a,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^f CENTRE HOSPITALIER DE VERSAILLES   (France)

^g ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Cystic fibrosis; Hepatitis B; Immunization; Influenza; Vaccine coverage

Indexed keywords

BCG VACCINE; CHICKENPOX VACCINE; DIPHTHERIA POLIOMYELITIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; WART VIRUS VACCINE; VIRUS VACCINE;

ADOLESCENT; ARTICLE; CHILD; CYSTIC FIBROSIS; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; PANDEMIC INFLUENZA; SEASONAL INFLUENZA; VACCINATION; CLINICAL TRIAL; COMPLICATION; FEMALE; FRANCE; INCIDENCE; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; UTILIZATION; VIRUS DISEASES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; FRANCE; HUMANS; INCIDENCE; INFANT; MALE; PROSPECTIVE STUDIES; VACCINATION; VIRAL VACCINES; VIRUS DISEASES;

EID: 84940960383     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.04.006     Document Type: Article

References (31)

1. Gaudelus J. Immunisation contre l'hépatite B en France. Rev Prat 2010, 60(10):1373-1376.
2. Malfroot A., Adam G., Ciofu O., Doring G., Knoop C., Lang A.B., et al. Immunisation in the current management of cystic fibrosis patients. J Cyst Fibros 2005, 4(2):77-87.
3. Sanitaire INdV Calendrier des vaccinations et recommandations vaccinales 2009 selon l'avis du Haut conseil de la santé publique [cited 2014 12 December 2014]; Available from:. http://www.invs.sante.fr/beh/2009/16_17/.
4. Viviani L., Assael B.M., Kerem E. Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. J Cyst Fibros 2011, 10(5):370-376.
5. Debray D., Kelly D., Houwen R., Strandvik B., Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros 2011, 10(Suppl. 2):S29-S36.
6. Lindblad A., Glaumann H., Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology 1999, 30(5):1151-1158.
7. MacDonald N.E., Morris R.F., Beaudry P.H. Varicella in children with cystic fibrosis. Pediatr Infect Dis J 1987, 6(4):414-416.
8. Pandolfi E., Marino M.G., Carloni E., Romano M., Gesualdo F., Borgia P., et al. The effect of physician's recommendation on seasonal influenza immunization in children with chronic diseases. BMC Public Health 2012, 12:984.
9. Launay O., Boelle P.Y., Krivine A., Grenet D., Boussaud V., Remus N., et al. Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis. Vaccine 2014, 32(35):4515-4521.
10. INVS Couverture vaccinale 5/09/2014 [cited 2015 10/03/2015]; Available from:. http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Couverture-vaccinale.
11. Jean-Paul Guthmann L.F., Lévy-Bruhl Daniel Mesure de la couverture vaccinale en France 2012, Institut National de Veille Sanitaire.
12. Pandolfi E., Carloni E., Marino M.G., Ciofi degli Atti M.L., Gesualdo F., Romano M., et al. Immunization coverage and timeliness of vaccination in Italian children with chronic diseases. Vaccine 2012, 30(34):5172-5178.
13. Weil-Olivier C., Angoulvant F., Chevallier B., De Montalembert M., Gaudelus J., Quinet B., et al. Influenza vaccination coverage rate in children with underlying chronic disorders in 7 French pediatric wards. Arch Pediatr 2006, 13(10):1287-1293.
14. Rance F., Chave C., de Blic J., Deschildre A., Donato L., Dubus J.C., et al. Couverture vaccinale contre la grippe chez les enfants asthmatiques en France en 2006-2007. Arch Pediatr 2008, 15(11):1724-1728.
15. Greenwood V.J., Crawford N.W., Walstab J.E., Reddihough D.S. Immunisation coverage in children with cerebral palsy compared with the general population. J Paediatr Child Health 2013, 49(2):E137-E141.
16. Esposito S., Mastrolia M.V., Prada E., Pietrasanta C., Principi N. Vaccine administration in children with chronic kidney disease. Vaccine 2014, 32(49):6601-6606.
17. Esposito S., Marchisio P., Droghetti R., Lambertini L., Faelli N., Bosis S., et al. Influenza vaccination coverage among children with high-risk medical conditions. Vaccine 2006, 24(24):5251-5255.
18. d'Alessandro E., Hubert D., Launay O., Bassinet L., Lortholary O., Jaffre Y., et al. Determinants of refusal of A/H1N1 pandemic vaccination in a high risk population: a qualitative approach. PLoS One 2012, 7(4):e34054.
19. Kumar M., Herrera J.L. Importance of hepatitis vaccination in patients with chronic liver disease. South Med J 2010, 103(12):1223-1231.
20. Lamireau T., Monnereau S., Martin S., Marcotte J.E., Winnock M., Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol 2004, 41(6):920-925.
21. Debray D. L'atteinte hépatique de la mucoviscidose. Arch Pediatr 2012, 19(Suppl. 1):S23-S26.
22. Shapiro A.J., Esther C.R., Leigh M.W., Dellon E.P. Vaccine induced hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease. Vaccine 2013, 31(6):906-911.
23. Santé HAd Mucoviscidose Protocole national de diagnostic et de soins pour une maladie rare 12 December 2014 [cited 2014 12 December 2014]; [1-34]. Available from:. http://www.has-sante.fr/portail/upload/docs/application/pdf/07-025-mucovisidose-guide_sans_lap.pdf.
24. Mikaeloff Y., Caridade G., Suissa S., Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009, 72(10):873-880.
25. Sermet-Gaudelus I., Couderc L., Vrielynck S., Brouard J., Weiss L., Wizla N., et al. Recommandations nationales pour la prise en charge du nourrisson dépisté atteint de mucoviscidose. Consensus de la fédération des centres de ressources et de compétences de la mucoviscidose. Arch Pediatr 2014, 21(6):654-662.
26. Ortiz J.R., Neuzil K.M., Victor J.C., Wald A., Aitken M.L., Goss C.H. Influenza-associated cystic fibrosis pulmonary exacerbations. Chest 2010, 137(4):852-860.
27. Murris-Espin M., Aubert M., Bosdure E., Dubus J.C. Influenza vaccination coverage in patients with cystic fibrosis followed at 12 care centers in the Greater South Region of France for the season 2005/2006. Vaccine 2008, 26(44):5612-5618.
28. Blank P.R., Bonnelye G., Ducastel A., Szucs T.D. Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010. PLoS One 2012, 7(10):e45450.
29. Browning M.J., Lim M.T., Kenia P., Whittle M., Doffinger R., Barcenas-Morales G., et al. Pneumococcal polysaccharide vaccine responses are impaired in a subgroup of children with cystic fibrosis. J Cyst Fibros 2014, 13:632-638.
30. Iordache L., Gaudelus J., Hubert D., Launay O. Vaccination des patients atteints de mucoviscidose. Arch Pediatr 2012, 19(Suppl. 1):S36-S39.
31. Rawson H., Crampin A., Noah N. Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data. BMJ 2001, 323(7321):1091-1093.